Enhancer ID: | E_02_0732 |
Species: | human |
Position : | chr6:31572563-31574563 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 33028869 |
Enhancer experiment: | qRT-PCR |
Enhancer experiment description: | Further bioinformatic analysis, employing Ingenuity Pathway Analysis identifed signifcant enrichment in XAV-939-treated cells of functional categories and networks involved in TNF, NF?B, and STAT signaling. We identifed a Tankyrase inhibitor (XAV-939) as a powerful enhancer of osteoblastic diferentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with low bone formation. |
Target gene : | TNF |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Further bioinformatic analysis, employing Ingenuity Pathway Analysis identifed signifcant enrichment in XAV-939-treated cells of functional categories and networks involved in TNF, NF?B, and STAT signaling. We identifed a Tankyrase inhibitor (XAV-939) as a powerful enhancer of osteoblastic diferentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with low bone formation. |
TF name : | -- |
TF experiment: | qRT-PCR |
TF experiment description: | Further bioinformatic analysis, employing Ingenuity Pathway Analysis identifed signifcant enrichment in XAV-939-treated cells of functional categories and networks involved in TNF, NF?B, and STAT signaling. We identifed a Tankyrase inhibitor (XAV-939) as a powerful enhancer of osteoblastic diferentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with low bone formation. |
Enhancer function : | Further bioinformatic analysis, employing Ingenuity Pathway Analysis identifed signifcant enrichment in XAV-939-treated cells of functional categories and networks involved in TNF, NF?B, and STAT signaling. We identifed a Tankyrase inhibitor (XAV-939) as a powerful enhancer of osteoblastic diferentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with low bone formation. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Further bioinformatic analysis, employing Ingenuity Pathway Analysis identifed signifcant enrichment in XAV-939-treated cells of functional categories and networks involved in TNF, NF?B, and STAT signaling. We identifed a Tankyrase inhibitor (XAV-939) as a powerful enhancer of osteoblastic diferentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with low bone formation. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|